Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New-onset Type 1 Diabetes Mellitus”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Testing effectiveness (Phase 2)UnknownNCT02763423
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis

Who this might be right for
Ketoacidosis, Diabetic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Study completedNCT02218619
What this trial is testing

Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Robin Goland, MD 20
Testing effectiveness (Phase 2)Study completedNCT04129528
What this trial is testing

Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects

Who this might be right for
Type 1 Diabetes Mellitus
Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)Ended earlyNCT06025110
What this trial is testing

TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 1
ITB-Med LLC 9
Early research (Phase 1)WithdrawnNCT00214214
What this trial is testing

A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus

Who this might be right for
New Onset Type 1 Diabetes Mellitus
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT04270942
What this trial is testing

At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)

Who this might be right for
Diabetes Mellitus, Type 1
Provention Bio, a Sanofi Company 6
Large-scale testing (Phase 3)Study completedNCT01123083
What this trial is testing

Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 179
Testing effectiveness (Phase 2)UnknownNCT01947569
What this trial is testing

Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy

Who this might be right for
Treatment of Type I Diabetes Mellitus.
DiaVacs, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00505375
What this trial is testing

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112
Testing effectiveness (Phase 2)Looking for participantsNCT07187531
What this trial is testing

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
SAb Biotherapeutics, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT00279305
What this trial is testing

Rituximab in New Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 87
Post-approval studies (Phase 4)Study completedNCT01390480
What this trial is testing

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 31
Not applicableStudy completedNCT02801942
What this trial is testing

Immune Profile in Subjects With New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 22
Large-scale testing (Phase 3)Study completedNCT00678886
What this trial is testing

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 272
Large-scale testing (Phase 3)Looking for participantsNCT07222332
What this trial is testing

Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 300
Post-approval studies (Phase 4)Study completedNCT01269034
What this trial is testing

New Onset Type 1 Diabetes: Role of Exenatide

Who this might be right for
Type 1 Diabetes
Albert Einstein College of Medicine 13
Testing effectiveness (Phase 2)Study completedNCT00529399
What this trial is testing

Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 145
Testing effectiveness (Phase 2)UnknownNCT04078308
What this trial is testing

Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Insulin-Dependent
Royan Institute 20
Testing effectiveness (Phase 2)Study completedNCT01781975
What this trial is testing

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type IDiabetes Mellitus, Insulin-Dependent, 1Type 1 Diabetes Mellitus+2 more
University of California, San Francisco 67
Not applicableActive Not RecruitingNCT04007809
What this trial is testing

Phenotypic and Genotypic Characterization of New-onset Type I Diabetes

Who this might be right for
Type1diabetes
Université Catholique de Louvain 98
Load More Results